Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2000
10/31/2000CA1341131C Human nerve growth factor
10/31/2000CA1341130C Use of oxidoreductases in bleaching and/or detergent compositions and their preparation by microorganisms engineered by recombinant dna technology
10/27/2000CA2307108A1 Process for production of mammalian cell lines, produced cell lines and their uses
10/27/2000CA2307104A1 Human myoblast cell lines and their uses
10/26/2000WO2000063702A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes
10/26/2000WO2000063699A1 A tenascin-c isoform as a marker for neoplasias
10/26/2000WO2000063695A1 Encoding of microcarriers
10/26/2000WO2000063691A2 Method for detecting mismatches or mutations in nucleic acid
10/26/2000WO2000063690A1 Enriched antigen-specific t-cells, and related therapeutic and prophylactic compositions and methods
10/26/2000WO2000063677A1 Method and device for imaging and analysis of biopolymer arrays
10/26/2000WO2000063668A1 Apparatus and methods for sample delivery
10/26/2000WO2000063667A2 Methods for identifying modulators of n-type ion channel inactivation
10/26/2000WO2000063441A2 Single nucleotide polymorphisms in mitochondrial genes that segregate with alzheimer's disease
10/26/2000WO2000063438A2 Method of classifying a thyroid carcinoma using differential gene expression
10/26/2000WO2000063435A2 Method of identifying toxic agents using differential gene expression
10/26/2000WO2000063434A1 MinK-RELATED GENES, FORMATION OF POTASSIUM CHANNELS AND ASSOCIATION WITH CARDIAC ARRHYTHMIA
10/26/2000WO2000063433A1 PHARMACOLOGICAL TARGETING OF mRNA CAP FORMATION
10/26/2000WO2000063429A2 Automatable rapid test for detecting cancers, on the basis of telomerase(htc) mrna and specific primers and probes
10/26/2000WO2000063427A2 Compound screening method
10/26/2000WO2000063426A2 Compound screening methods
10/26/2000WO2000063425A2 Compound assay using nematodes
10/26/2000WO2000063419A1 Combinatorial chemical library supports having indicia at coding positions and methods of use
10/26/2000WO2000063417A2 Proteins that regulate systemic acquired resistance in plants
10/26/2000WO2000063415A1 Dna encoding the human vanilloid receptor vr1
10/26/2000WO2000063414A1 The rpoa gene of agrobacterium tumefaciens
10/26/2000WO2000063413A1 Agrobacterium tumefaciens rpoa gene
10/26/2000WO2000063410A1 Methods and compositions for transforming cells using site-specific recombination
10/26/2000WO2000063409A1 Endosomolytic agents and cell delivery systems
10/26/2000WO2000063406A2 Adenoviral vectors having nucleic acids encoding immunomodulatory molecules
10/26/2000WO2000063404A1 New expression systems using introns
10/26/2000WO2000063403A2 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein
10/26/2000WO2000063401A1 Regulated expression of genes in plant seeds
10/26/2000WO2000063400A2 Plant transformation process
10/26/2000WO2000063399A1 Glycogen branching enzymes and carbohydrates modified thereby
10/26/2000WO2000063398A1 Plant transformation method
10/26/2000WO2000063397A2 Methods for delivering inhibitory rna to plants and applications thereof
10/26/2000WO2000063396A1 Method for enhancing myoblast migration and invasion in the context of gene therapy
10/26/2000WO2000063395A1 Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof
10/26/2000WO2000063394A2 A polypeptide having amidolytic activity for a serpin
10/26/2000WO2000063393A1 Dsp-8 dual-specificity map kinase phosphatase
10/26/2000WO2000063392A1 Novel tyrosine phosphatase
10/26/2000WO2000063391A2 Nucleic acid sequences to proteins involved in tocopherol synthesis
10/26/2000WO2000063390A1 Splice variant of p101 protein
10/26/2000WO2000063389A1 Nucleic acid sequences to proteins involved in isoprenoid synthesis
10/26/2000WO2000063387A1 The full gene sequence of the donkey leukocyte vaccine strain of the equine infectious anemia virus and their application
10/26/2000WO2000063386A2 Prevention, diagnosis and treatment of lyme disease
10/26/2000WO2000063385A2 Nucleic acid immunization
10/26/2000WO2000063384A1 Streptokinase fragments and their use for inhibiting cell death
10/26/2000WO2000063383A1 IgA BINDING POLYPEPTIDE
10/26/2000WO2000063382A1 Genes and expression products from hematopoietic cells
10/26/2000WO2000063381A1 Mammalian protein with putative function in signal transduction
10/26/2000WO2000063380A1 Vascular endothelial cell growth factor variants and uses thereof
10/26/2000WO2000063379A2 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
10/26/2000WO2000063378A2 Zalpha13: a human secreted protein
10/26/2000WO2000063377A1 Adipocyte complement related protein homolog zacrp3
10/26/2000WO2000063376A1 Adipocyte complement related protein homolog zacrp2
10/26/2000WO2000063375A1 Dna encoding a kinesin-like protein (hklp) comprising biallelic markers
10/26/2000WO2000063374A1 Synthetic transmembrane components
10/26/2000WO2000063373A1 A method of altering the properties of a membrane-associated protein by substitution of the transmembrane domain
10/26/2000WO2000063372A1 Synthetic signalling molecules
10/26/2000WO2000063371A1 Protease activated receptor 2 variants
10/26/2000WO2000063370A2 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes
10/26/2000WO2000063369A2 Gene therapy
10/26/2000WO2000063368A1 Recombinant protein uk114 and its use in therapy and diagnostics
10/26/2000WO2000063367A1 A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof
10/26/2000WO2000063366A2 Improved antisense oligomers
10/26/2000WO2000063365A1 Locked nucleic acid hybrids and methods of use
10/26/2000WO2000063364A2 Methods and compositions for inhibiting the function of polynucleotide sequences
10/26/2000WO2000063362A1 Magnetic dna extraction kit for plants
10/26/2000WO2000063361A2 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides
10/26/2000WO2000063360A1 Combinatorial method for producing nucleic acids
10/26/2000WO2000063356A2 Herbicidal seed treatment
10/26/2000WO2000063355A1 Method for treatment of an aqueous flux by electropulsation of a field parallel to the flow, pulsation chamber and uses thereof
10/26/2000WO2000063354A1 Novel amidase gene
10/26/2000WO2000063353A1 Human kinesins and methods of producing and purifying human kinesins
10/26/2000WO2000063352A2 Human homologues of fused gene
10/26/2000WO2000063351A2 Carbohydrate-modifying enzymes
10/26/2000WO2000063349A1 Human hac3
10/26/2000WO2000063347A1 Methods for enhancing plant defense
10/26/2000WO2000063346A1 A bacillus protein production cell
10/26/2000WO2000063252A1 Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor
10/26/2000WO2000063247A2 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
10/26/2000WO2000063245A2 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant
10/26/2000WO2000063243A1 Derivatives of the b or z domain from staphylococcal protein a (spa) interacting with at least one domain of human factor viii
10/26/2000WO2000063241A2 Methods and compositions for modulating an immune response
10/26/2000WO2000063230A2 49 human secreted proteins
10/26/2000WO2000063221A2 Galectin 11
10/26/2000WO2000062931A1 The use of microfluidic systems in the electrochemical detection of target analytes
10/26/2000WO2000062815A2 Novel pharmaceutical composition suitable for gene therapy
10/26/2000WO2000062804A2 Identification of sortase gene
10/26/2000WO2000062800A2 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
10/26/2000WO2000062736A2 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
10/26/2000WO2000062605A1 eNOS MUTATIONS USEFUL FOR GENE THERAPY AND THERAPEUTIC SCREENING
10/26/2000WO2000062604A1 Genetic system for controlling background expression of transgene products
10/26/2000WO2000062601A1 Agrobacterium-mediated genetic transformation of multicellular marine algae, resultant strains and their products
10/26/2000WO2000040727A3 Recombinant growth factor with the biological activity of a g-csf (granulocyte colony stimulating factor)
10/26/2000WO2000040719A3 Tissue repair protein involved in orofacial clefting and uses thereof
10/26/2000WO2000039319A3 Target cell-specific adenoviral vectors containing e3 and methods of use thereof
10/26/2000WO2000039306A3 Detergent compositions comprising phenol oxidizing enzymes from fungi
10/26/2000WO2000039275A3 Multiple shear stress responsive elements (ssre) and methods of use thereof
1 ... 3164 3165 3166 3167 3168 3169 3170 3171 3172 3173 3174 3175 3176 3177 3178 3179 3180 3181 3182 3183 3184 ... 4023